cilofexor (GS-9674) / Gilead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cilofexor (GS-9674) / Gilead
NCT02654002: Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics

Completed
1
120
US
Cilofexor, GS-9674, Placebo
Gilead Sciences
Nonalcoholic Steatohepatitis (NASH)
07/16
07/16
NCT02808312: Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function

Completed
1
57
US, RoW
Cilofexor, GS-9674
Gilead Sciences
Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC)
10/18
10/18
NCT04060147: Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis

Terminated
1
11
US
Cilofexor, CILO, GS-9674
Gilead Sciences
Primary Sclerosing Cholangitis, Compensated Cirrhosis
09/21
09/21

Download Options